James Molloy
Stock Analyst at Alliance Global Partners
(0.32)
# 4,442
Out of 5,238 analysts
31
Total ratings
20%
Success rate
-42.94%
Average return
Main Sectors:
Stocks Rated by James Molloy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVPH Reviva Pharmaceuticals Holdings | Maintains: Buy | $16 → $30 | $0.86 | +3,404.67% | 2 | Mar 30, 2026 | |
| SNGX Soligenix | Maintains: Buy | $10 → $6 | $0.29 | +1,947.78% | 1 | Jul 16, 2025 | |
| IGC IGC Pharma | Reiterates: Buy | $3.5 | $0.31 | +1,025.40% | 2 | Mar 6, 2025 | |
| INTS Intensity Therapeutics | Initiates: Buy | $213 | $5.09 | +4,074.85% | 1 | Jan 13, 2025 | |
| VTVT vTv Therapeutics | Initiates: Buy | $35 | $30.68 | +14.08% | 1 | Dec 9, 2024 | |
| GOVX GeoVax Labs | Initiates: Buy | $375 | $1.67 | +22,355.09% | 1 | Nov 11, 2024 | |
| INMB INmune Bio | Initiates: Buy | $20 | $1.43 | +1,298.60% | 1 | Oct 21, 2024 | |
| SCLX Scilex Holding Company | Initiates: Buy | $490 | $7.82 | +6,165.98% | 1 | Oct 16, 2024 | |
| TNXP Tonix Pharmaceuticals Holding | Maintains: Buy | $600 → $1,100 | $14.09 | +7,706.96% | 7 | Jul 22, 2024 | |
| PED PEDEVCO | Initiates: Buy | $35 | $13.98 | +150.36% | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $4.39 | +127.79% | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7.5 | $0.88 | +752.27% | 1 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $5.90 | +238.98% | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $5.01 | +59.68% | 1 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $7 | $4.32 | +62.04% | 2 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,200 | $6.25 | +51,100.00% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $2.09 | +13,297.13% | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $196 | $2.72 | +7,093.01% | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,400 | $5.93 | +141,552.61% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $150 | $0.88 | +16,947.39% | 1 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11,250 | $2.85 | +394,636.84% | 1 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $5.21 | +379.85% | 1 | Oct 4, 2021 |
Reviva Pharmaceuticals Holdings
Mar 30, 2026
Maintains: Buy
Price Target: $16 → $30
Current: $0.86
Upside: +3,404.67%
Soligenix
Jul 16, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.29
Upside: +1,947.78%
IGC Pharma
Mar 6, 2025
Reiterates: Buy
Price Target: $3.5
Current: $0.31
Upside: +1,025.40%
Intensity Therapeutics
Jan 13, 2025
Initiates: Buy
Price Target: $213
Current: $5.09
Upside: +4,074.85%
vTv Therapeutics
Dec 9, 2024
Initiates: Buy
Price Target: $35
Current: $30.68
Upside: +14.08%
GeoVax Labs
Nov 11, 2024
Initiates: Buy
Price Target: $375
Current: $1.67
Upside: +22,355.09%
INmune Bio
Oct 21, 2024
Initiates: Buy
Price Target: $20
Current: $1.43
Upside: +1,298.60%
Scilex Holding Company
Oct 16, 2024
Initiates: Buy
Price Target: $490
Current: $7.82
Upside: +6,165.98%
Tonix Pharmaceuticals Holding
Jul 22, 2024
Maintains: Buy
Price Target: $600 → $1,100
Current: $14.09
Upside: +7,706.96%
PEDEVCO
Jul 17, 2024
Initiates: Buy
Price Target: $35
Current: $13.98
Upside: +150.36%
Jul 17, 2024
Initiates: Buy
Price Target: $10
Current: $4.39
Upside: +127.79%
Jul 17, 2023
Initiates: Buy
Price Target: $7.5
Current: $0.88
Upside: +752.27%
May 24, 2023
Reiterates: Buy
Price Target: $20
Current: $5.90
Upside: +238.98%
Nov 15, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $5.01
Upside: +59.68%
Nov 4, 2022
Maintains: Buy
Price Target: $10 → $7
Current: $4.32
Upside: +62.04%
Nov 1, 2022
Initiates: Buy
Price Target: $3,200
Current: $6.25
Upside: +51,100.00%
Oct 20, 2022
Initiates: Buy
Price Target: $280
Current: $2.09
Upside: +13,297.13%
Oct 13, 2022
Initiates: Buy
Price Target: $196
Current: $2.72
Upside: +7,093.01%
Sep 7, 2022
Initiates: Buy
Price Target: $8,400
Current: $5.93
Upside: +141,552.61%
Aug 25, 2022
Initiates: Buy
Price Target: $150
Current: $0.88
Upside: +16,947.39%
Jun 1, 2022
Initiates: Buy
Price Target: $11,250
Current: $2.85
Upside: +394,636.84%
Oct 4, 2021
Initiates: Buy
Price Target: $25
Current: $5.21
Upside: +379.85%